Kovitz Investment Group Partners
RMD icon

Kovitz Investment Group Partners’s ResMed RMD Stock Holding History

Kovitz Investment Group Partners’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,478
Closed -$952K – 1134
2025
Q3 		$952K Buy
3,478
+386
+12% +$105K ﹤0.01% 854
2025
Q2 		$798K Buy
3,092
+155
+5% +$37K ﹤0.01% 851
2025
Q1 		$658K Sell
2,937
-171
-6% -$39.9K ﹤0.01% 842
2024
Q4 		$711K Buy
+3,108
New +$748K ﹤0.01% 802

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Kovitz Investment Group Partners's RMD Position: Q4 2025 in Review

Kovitz Investment Group Partners sold out of ResMed (RMD) in Q4 2025, closing a stake of 3,478 shares — an estimated $952K sold.

Kovitz Investment Group Partners first reported a position in RMD in Q4 2024 and held it in 4 quarters. The position peaked at $952K in Q3 2025. 948 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

  • Kovitz Investment Group Partners reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
  • Kovitz Investment Group Partners sold 3,478 ResMed shares in Q4 2025, an estimated $952K.
  • Kovitz Investment Group Partners first reported a position in ResMed in Q4 2024 and held it in 4 quarters.
  • Kovitz Investment Group Partners's ResMed position peaked at $952K in Q3 2025.
  • 948 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on Kovitz Investment Group Partners's 13F filing for Q4 2025, filed 20 Feb 2026.